Top Buy
Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | €73.50 | - | - |
Knight Therapeutics | 1 | 0 | 0 | 0 | €4.12 | €10.00 | 142.718% |
Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.54 | €4.00 | 57.480% |
Cellectar BioSciences Inc. | 7 | 8 | 0 | 0 | €2.86 | €10.55 | 268.734% |
Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €39.60 | €50.00 | 26.263% |
Poxel S.A. | 1 | 0 | 0 | 0 | €0.63 | €0.70 | 10.410% |
Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €67.28 | €100.00 | 48.633% |
Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.15 | €19.86 | 223.007% |
Vericel Corp. | 1 | 0 | 0 | 0 | €44.80 | - | - |
Brainstorm Cell | 1 | 0 | 0 | 0 | €0.35 | - | - |
Faes Farma S.A. | 1 | 0 | 0 | 0 | €3.54 | €6.00 | 69.731% |
Syros Pharmaceuticals Inc. | 5 | 1 | 0 | 1 | €4.78 | €12.80 | 167.814% |
Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
Trinity Biotech ADR | 22 | 0 | 0 | 0 | €0.41 | - | - |
Immutep LTD ADR | 1 | 0 | 0 | 0 | €2.68 | €4.00 | 49.254% |
Verastem Inc. | 9 | 0 | 0 | 0 | €11.10 | €27.03 | 143.523% |
Immunic Inc. | 6 | 3 | 0 | 2 | €1.18 | €5.48 | 364.953% |
Virbac S.A. | 1 | 0 | 0 | 0 | €352.00 | - | - |
UCB S.A. | 2 | 0 | 0 | 0 | €123.05 | - | - |
Perrigo Co. plc | 3 | 0 | 0 | 0 | €28.50 | €35.99 | 26.264% |
Sensorion SA | 2 | 0 | 0 | 0 | €0.69 | - | - |
Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
WAVE Life Sciences Ltd | 8 | 0 | 0 | 0 | €5.25 | €9.10 | 73.349% |
GSK plc | 1 | 0 | 0 | 0 | €20.87 | - | - |